Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastrointestinal Cancers
•
Medical Oncology
How would you treat unresectable serous cystadenoma of the pancreas involving the liver?
Related Questions
After R1 resection of a locally advanced, node-positive neuroendocrine tumor of the terminal ilium, would you offer adjuvant radiation therapy?
How would you approach a gastric GIST with R1 resection?
How, if at all, are you employing ctDNA in the management of patients with colon cancer?
How do you sequence hypofractionated radiation and systemic therapy for patients with unresectable cholangiocarcinoma?
What is your preferred first line therapy in well differentiated GI NET with Ki67 > 55%?
Are durva/cis/gem or pembro/cis/gem less efficacious in cholangiocarcinomas with FGFR2 fusions?
In a patient with amyloidosis and abnormal liver function but child Pugh A, would you still proceed with SABR for a liver metastasis?
Is there data to support a 3 weeks regimen of panitumumab with maintenance capecitabine in colon cancer?
How would you manage a patient with T4N1 duodenal adenocarcinoma by EUS with ampullary invasion that is dMMR?
In patients with active IBD and rectal cancer, do you take any precautions before starting TNT?
